Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
103.37
-2.59 (-2.44%)
Dec 19, 2024, 12:49 PM EST - Market open

Novo Nordisk Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
198.11B 192.75B 182.45B 173.47B 161.15B 154.71B 147.23B 139.55B
Diabetes Growth
22.93% 24.59% 23.92% 24.31% 21.21% 23.23% 23.53% 23.28%
Obesity
54.97B 48.42B 44.83B 41.63B 35.89B 27.97B 21.30B 16.86B
Obesity Growth
53.16% 73.14% 110.41% 146.87% 159.42% 134.98% 107.82% 100.76%
Rare Disease
17.51B 16.83B 16.97B 17.16B 17.45B 18.65B 19.76B 20.54B
Rare Disease Growth
0.34% -9.75% -14.09% -16.45% -14.49% -5.81% 0.85% 6.97%

Operating Income by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
117.71B 110.96B 106.68B 99.62B 90.58B 82.01B 75.18B 67.40B
Diabetes and Obesity Care Growth
29.95% 35.29% 41.90% 47.82% 45.45% 43.47% 40.66% 36.05%
Rare Disease
661.00M 504.00M 2.74B 2.95B 2.32B 4.15B 5.49B 7.41B
Rare Disease Growth
-71.50% -87.86% -50.18% -60.20% -74.47% -55.13% -41.36% -18.58%

Revenue by Geography
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
165.43B 157.88B 146.61B 136.63B 120.67B 109.37B 100.41B 91.11B
North America Growth
37.09% 44.35% 46.01% 49.97% 42.69% 40.05% 39.09% 35.45%
International
105.15B 100.12B 97.63B 95.63B 93.82B 91.95B 87.88B 85.85B
International Growth
12.08% 8.89% 11.10% 11.40% 13.54% 16.16% 14.38% 16.74%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.